Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Stomach Neoplasms 2Gastroesophageal Reflux 2Barrett Esophagus 2Zollinger-Ellison Syndrome 1Xerostomia 1Stomach Ulcer 1Pseudomyxoma Peritonei 1Oropharyngeal Neoplasms 1Mucositis 1Hemorrhage 1Helicobacter Infections 1Heartburn 1Head and Neck Neoplasms 1Gastritis, Atrophic 1Esophagitis, Peptic 1Appendiceal Neoplasms 1

Interventions

Surveys and Questionnaires 2Mitomycin 2Hyperthermic Intraperitoneal Chemotherapy 2irinotecan sucrosofate 1Specimen Handling 1Referral and Consultation 1Oxaliplatin 1Observation 1Nivolumab 1Magnetic Resonance Spectroscopy 1Leucovorin 1Lansoprazole 1Ipilimumab 1Floxuridine 1Cytoreduction Surgical Procedures 1Clarithromycin 1CTLA-4 Antigen 1Amoxicillin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Pseudomyxoma Peritonei × Lansoprazole × Gastrointestinal × Clear all
NCT02387203 2024-11-19

Antibiotic Treatment and Long-term Outcomes of Patients With Pseudomyxoma Peritonei of Appendiceal Origin

Mercy Medical Center

Phase 2 Active not recruiting
80 enrolled
Gastrointestinal

Appendiceal Neoplasms, Pseudomyxoma Peritonei

Data powered by HemOnc (CC BY 4.0) Colophon âš¡